Supernus Pharmaceuticals Market Sentiment

Supernus Pharmaceuticals Inc

SUPNNASDAQ

$37.80

-1.77-4.48%

Last update: Oct 16, 2:27 PM

$39.52

-0.05-0.13%

Supernus Pharmaceuticals Market Sentiment - Benzinga

Market sentiment signals for Supernus Pharmaceuticals (SUPN): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▲ 10.5% short float

Options Flow▼ 1.59 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

5 analysts

Options Flow (P/C)

1.59

More puts — Bearish

22 calls · 35 puts

Avg Consensus PT

$62

+65.1%

Highest Price Target

$67

+77.3%

Cantor Fitzgerald

Lowest Price Target

$55

+45.5%

Stifel

Short Interest

10.5%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jul 9, 2026	Cantor Fitzgerald	Kristen Kluska—	+77.3%	$63 → $67	Maintained	Overweight
Dec 19, 2025	Stifel	Annabel Samimy—	+45.5%	$50 → $55	Maintained	Hold
Oct 29, 2025	B of A Securities	Pavan Patel—	+72.0%	$65	Initiate	Buy
Oct 23, 2025	TD Cowen	Stacy Ku—	+58.7%	$45 → $60	Maintained	Buy
Oct 9, 2025	Piper Sandler	David Amsellem—	+72.0%	$40 → $65	Upgrade	Neutral→Overweight
Sep 30, 2025	Cantor Fitzgerald	Kristen Kluska—	+66.7%	$46 → $63	Maintained	Overweight
Aug 29, 2025	Piper Sandler	David Amsellem—	+5.8%	$36 → $40	Maintained	Neutral
Aug 6, 2025	Cantor Fitzgerald	Kristen Kluska—	+21.7%	$42 → $46	Maintained	Overweight
Feb 26, 2025	Cantor Fitzgerald	Kristen Kluska—	-4.8%	$36 → $36	Maintained	Neutral
Feb 19, 2025	Cantor Fitzgerald	Kristen Kluska—	-4.8%	$57 → $36	Downgrade	Overweight→Neutral
Sep 11, 2024	Piper Sandler	David Amsellem—	-4.8%	$41 → $36	Downgrade	Overweight→Neutral
Feb 28, 2024	Piper Sandler	David Amsellem—	+8.5%	$45 → $41	Maintained	Overweight
Nov 9, 2023	Piper Sandler	David Amsellem—	+13.8%	$42 → $43	Maintained	Overweight
Oct 25, 2023	Piper Sandler	David Amsellem—	+11.1%	$43 → $42	Maintained	Overweight